The NSE and S100β proteins have been demonstrated to provide quantitative measures of brain damage and/or to improve the diagnosis and outcome evaluation in ischemic stroke, intracerebral hemorrhage, seizures, and comatose patients after cardiopulmonary resuscitation for cardiac arrest and traumatic brain injury [32–34]. Here, S100B is linked to ischemic stroke.